Aclaris Therapeutics Inc (ACRS) stock has fallen -95.55% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives ACRS stock a score of 32 out of a possible 100.
That rank is primarily influenced by a short-term technical score of 0. ACRS's rank also includes a long-term technical score of 0.
ACRS has an Overall Score of 32. Find out what this means to you and get the rest of the rankings on ACRS!
Aclaris Therapeutics Inc (ACRS) stock is unmoved 0% while the S&P 500 has fallen -0.09% as of 4:00 PM on Wednesday, Nov 15. ACRS is unmoved $0.00 from the previous closing price of $0.80 on volume of 182,416 shares. Over the past year the S&P 500 is up 13.64% while ACRS has fallen -95.55%. ACRS lost -$1.67 per share in the over the last 12 months.
Click Here to get the full Stock Report for Aclaris Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
